XML 45 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Dispositions (Tables)
6 Months Ended
Jun. 30, 2016
Discontinued Operations and Disposal Groups [Abstract]  
Major Classes of Assets Sold and Gain Recognized
The following table presents the consideration received, major classes of assets sold and the gain recognized on the sale of the Non-Core ACC Products:
 
(in thousands)
Sale price:
 
Cash
$
263,807

Contingent purchase price from sale of business
65,700

Total sale price
329,507

 
 
Assets:
 
Inventory
2,184

Intangibles
5,210

Goodwill
33,812

Total assets sold
41,206

 
 
Gain on sale of business
$
288,301

The significant cash flow items from discontinued operations for the six months ended June 30, 2016 and 2015 were as follows:

 
Six Months Ended June 30,
 
2016
 
2015
 
(in thousands)
Depreciation from discontinued operations
$

 
$
144

Amortization from discontinued operations

 
9,021

Gain on sale of business
(1,004
)
 

Change in contingent consideration obligation

 
(900
)
Proceeds from sale of business
174,068

 

Capital expenditures

 
406



The following table presents the major classes of assets and liabilities at December 31, 2015 related to the Hemostasis Business which were reclassified as held for sale:
 
December 31,
2015
 
(in thousands)
Assets:
 
Inventory
$
53,765

Prepaid expenses and other current assets
1,153

Fixed assets, net
1,913

Intangibles, net
374,779

Allowance for reduction of assets of business held for sale
(108,773
)
Total assets held for sale
$
322,837

 
 
Liabilities:
 
Contingent purchase price – current
$
28,600

Deferred tax liability
38,915

Total liabilities held for sale
$
67,515

The following table presents key financial results of the Hemostasis Business included in “Income (loss) from discontinued operations, net of tax” for the three and six months ended June 30, 2016 and 2015:

 
Three Months Ended
June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(in thousands)
Net product revenues
$
(12
)
 
$
15,953

 
$
50

 
$
32,355

Operating expenses:
 
 
 
 
 
 
 
Cost of product revenue
(589
)
 
12,244

 
1,704

 
25,443

Research and development
(27
)
 
3,187

 
119

 
3,853

Selling, general and administrative
(15
)
 
2,937

 
678

 
2,687

Total operating expenses
(631
)
 
18,368

 
2,501

 
31,983

Income (loss) from operations
619

 
(2,415
)
 
(2,451
)
 
372

Gain from sale of business

 

 
1,004

 

Other expense, net

 
(139
)
 
(39
)
 
(489
)
Income (loss) from discontinued operations before income taxes
619

 
(2,554
)
 
(1,486
)
 
(117
)
Benefit for income taxes

 
(23,407
)
 

 
(21,631
)
Income (loss) from discontinued operations, net of tax
$
619

 
$
20,853

 
$
(1,486
)
 
$
21,514